Your browser doesn't support javascript.
loading
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.
Brudno, Jennifer N; Natrakul, Danielle A; Karrs, Jeremiah; Patel, Nisha; Maass-Moreno, Roberto; Ahlman, Mark A; Mikkilineni, Lekha; Mann, Jennifer; Stroncek, David F; Highfill, Steven L; Fromm, Genevieve C; Patel, Rashmika; Pittaluga, Stefania; Kochenderfer, James N.
Afiliação
  • Brudno JN; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Natrakul DA; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Karrs J; Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Patel N; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Maass-Moreno R; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Ahlman MA; Department of Radiology and Imaging, Medical College of Georgia, Augusta, GA.
  • Mikkilineni L; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Mann J; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Stroncek DF; Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Highfill SL; Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, MD.
  • Fromm GC; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Patel R; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Pittaluga S; Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Kochenderfer JN; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Blood Adv ; 8(3): 802-814, 2024 Feb 13.
Article em En | MEDLINE | ID: mdl-37939262
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfoma Anaplásico de Células Grandes / Receptores de Antígenos Quiméricos / Linfoma Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Moldávia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfoma Anaplásico de Células Grandes / Receptores de Antígenos Quiméricos / Linfoma Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Moldávia